Literature DB >> 2870773

Opioid-induced feeding: localization of sensitive brain sites.

B A Gosnell, J E Morley, A S Levine.   

Abstract

These experiments were designed to identify brain sites at which opioids might act to influence ingestive behavior and to determine which opioid receptor types are involved. After food deprivation, rats were given microinjections of naloxone into several brain regions and food intake was measured. Injections into or near the paraventricular (PVN) or ventromedial (VMH) hypothalamic nuclei or the globus pallidus (GP) reduced food intake; injections into the striatum or lateral hypothalamus (LH) were ineffective. A second study examined the ingestive effects of roughly equimolar doses (1.43-1.75 nmol) of dynorphin A (DYN), beta-endorphin (beta-END), and D-Ala2,D-Leu5-enkephalin (DADLE) when injected into 4 different brain regions. Only DYN significantly increased food intake, and this effect was seen only with injections into the PVN and VMH. Beta-END stimulated water intake when injected into the PVN, VMH and GP but not the LH. Further studies indicated that with PVN injections, DYN was effective at a dose as low as 0.47 nmol, and that a higher dose of DADLE (4.39 nmol) did stimulate food intake. These studies support an important role for dynorphin and the kappa opioid receptor in the regulation of feeding and suggest that the opioid regulation of food and water intake can be differentiated both by sites of action and by effective agonists.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2870773     DOI: 10.1016/0006-8993(86)90526-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  12 in total

Review 1.  Endorphins: the basis of pleasure?

Authors:  C H Hawkes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-04       Impact factor: 10.154

Review 2.  Appetite regulation: the role of peptides and hormones.

Authors:  J E Morley
Journal:  J Endocrinol Invest       Date:  1989-02       Impact factor: 4.256

3.  Pre- and postsynaptic actions of opioid and orphan opioid agonists in the rat arcuate nucleus and ventromedial hypothalamus in vitro.

Authors:  P J Emmerson; R J Miller
Journal:  J Physiol       Date:  1999-06-01       Impact factor: 5.182

4.  Nociceptin/orphanin FQ suppresses the excitability of neurons in the ventromedial nucleus of the hypothalamus.

Authors:  Melissa J Chee; Christopher J Price; Michael A Statnick; William F Colmers
Journal:  J Physiol       Date:  2011-04-18       Impact factor: 5.182

5.  Striatal regulation of morphine-induced hyperphagia: an anatomical mapping study.

Authors:  V P Bakshi; A E Kelley
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  Effects of opioid antagonists naloxone and naltrexone on neuropeptide Y-induced feeding and brown fat thermogenesis in the rat. Neural site of action.

Authors:  C M Kotz; M K Grace; J Briggs; A S Levine; C J Billington
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

7.  Opioids in the hypothalamic paraventricular nucleus stimulate ethanol intake.

Authors:  Jessica R Barson; Ambrose J Carr; Jennifer E Soun; Nasim C Sobhani; Pedro Rada; Sarah F Leibowitz; Bartley G Hoebel
Journal:  Alcohol Clin Exp Res       Date:  2009-11-24       Impact factor: 3.455

8.  Opioids in the hypothalamus control dopamine and acetylcholine levels in the nucleus accumbens.

Authors:  Pedro Rada; Jessica R Barson; Sarah F Leibowitz; Bartley G Hoebel
Journal:  Brain Res       Date:  2009-11-27       Impact factor: 3.252

9.  Opioids in the nucleus accumbens stimulate ethanol intake.

Authors:  Jessica R Barson; Ambrose J Carr; Jennifer E Soun; Nasim C Sobhani; Sarah F Leibowitz; Bartley G Hoebel
Journal:  Physiol Behav       Date:  2009-08-06

10.  Morphine induced changes in ethanol-and water-intake are attenuated by the 5-HT3/4 antagonist tropisetron (ICS 205-930).

Authors:  C W Hodge; J S Niehus; H H Samson
Journal:  Psychopharmacology (Berl)       Date:  1995-05       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.